From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery ##### Up next ![LG Innotek Showcases Next‑Generation Semiconductor Substrate Technologies to Global Big Tech Companies at ECTC](https://i0.wp.com/mma.prnasia.com/media2/2988403/LG______________FC_BGA__________2.jpg?resize=200%2C110&ssl=1 "LG Innotek Showcases Next‑Generation Semiconductor Substrate Technologies to Global Big Tech Companies at ECTC") [](https://thailandbusinessnews.net/press-release/lg-innotek-showcases-next-generation-semiconductor-substrate-technologies-to-global-big-tech-companies-at-ectc/) ###### [LG Innotek Showcases Next‑Generation Semiconductor Substrate Technologies to Global Big Tech Companies at ECTC](https://thailandbusinessnews.net/press-release/lg-innotek-showcases-next-generation-semiconductor-substrate-technologies-to-global-big-tech-companies-at-ectc/) Published on 27 May 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/2934554/Viva_Logo.jpg?p=medium600 "logo")SHANGHAI, May 27, 2026 /PRNewswire/ — On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice President & Head of Early Discovery Platforms, and Dr. Tim Dwight, Senior Director of Medicinal Chemistry & Business Development. The discussion focused on how teams can make informed decisions when target biology, assay readiness, chemical tractability, and development requirements evolve in parallel. The speakers discussed how an integrated screening and medicinal chemistry workflow can support decision-making from hit identification through lead optimization. Dr. Xia emphasized that hit identification is highly target-dependent. Strategy selection should begin with target context, including biological validation, tractability, assay readiness, structural information, protein availability, resource constraints, and the IP and competitive landscape. Depending on the target, fragment-based drug discovery, virtual screening, HTS, DEL, ASMS, or SPR may each provide suitable entry points. The webinar also highlighted V-DEL-facilitated target triage as one of Viva Biotech’s practical approaches for early target and modality assessment. By integrating DEL screening outcomes, protein science expertise, protein QC and conformational-state assessment, and an AI-powered V-DEL Friendly Index, this approach can help assess ligandability, rank targets or constructs, prioritize resources, and inform suitable modality directions. The speakers noted that primary screening readouts are only the starting point. To advance a hit with confidence, teams need layered validation, including purity and liability checks, dose-response confirmation, orthogonal assays, selectivity and counter-screening, cytotoxicity assessment, and biophysical binding studies. Viva Biotech’s internal "promiscuous frequent hits" dataset also supports informed triage and helps reduce the risk of advancing misleading hits. From the medicinal chemistry perspective, Dr. Dwight emphasized that design–make–test–analyze cycles require clear hypotheses and close coordination across medicinal chemistry, AIDD/CADD, biology, DMPK, and project teams. Structure-based design, SAR analysis, FEP, MD simulations, ADMET prediction, and AI/ML-supported modeling can all contribute to focused compound prioritization. The discussion reinforced that integration is less about placing capabilities under one roof, and more about connecting the right data, expertise, and decision points, including go/no-go criteria. Through integrated protein science, structural biology, screening, medicinal chemistry, AIDD/CADD, biology, and DMPK, Viva Biotech supports a continuous discovery workflow from target understanding to validated hits and lead optimization with greater rigor, efficiency, and scientific discipline. [Source link ](http://www.prnasia.com/story/archive/4968913_AE68913_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/realty-one-group-announces-additional-leadership-promotions-to-accelerate-growth/) ![REALTY ONE GROUP ANNOUNCES ADDITIONAL LEADERSHIP PROMOTIONS TO ACCELERATE GROWTH](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/10/AZ-Asia-Pacific-partners-with-Green-Radar-to-enhance-its-email.jpeg?resize=260%2C140&ssl=1 "REALTY ONE GROUP ANNOUNCES ADDITIONAL LEADERSHIP PROMOTIONS TO ACCELERATE GROWTH") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## REALTY ONE GROUP ANNOUNCES ADDITIONAL LEADERSHIP PROMOTIONS TO ACCELERATE GROWTH LAGUNA NIGUEL, Calif., March 28, 2024 /PRNewswire/ — Realty ONE Group International,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - March 28, 2024 [](https://thailandbusinessnews.net/press-release/storika-closes-seed-round-to-scale-ai-native-creator-marketing-platform/) ![Storika Closes Seed Round to Scale AI-Native Creator Marketing Platform](https://i0.wp.com/mma.prnasia.com/media2/3003689/image1.jpg?resize=260%2C140&ssl=1 "Storika Closes Seed Round to Scale AI-Native Creator Marketing Platform") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Storika Closes Seed Round to Scale AI-Native Creator Marketing Platform Powered by an AI orchestration layer that automates the full influencer campaign… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - July 3, 2026 [](https://thailandbusinessnews.net/press-release/hyundai-bioscience-announces-clinical-development-plan-for-niclosamide-based-metabolic-anticancer-drug-targeting-p53-mutation-cancer/) ![Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/10/WuXi-Biologics-Congratulates-Amicus-Therapeutics-on-US-FDA-Approval-for.png?resize=260%2C140&ssl=1 "Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer The only solution for intractable cancer caused by mutations in the p53… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - April 25, 2024 ##### Most Read - [![DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") [DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") - [![Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") [Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") - [![ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") [ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") - [![GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") [GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") - [![Everest Medicines Announces Interim Results for First Half of 2026](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") [Everest Medicines Announces Interim Results for First Half of 2026](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") - [![Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/taiwantrade-com-brings-taiwans-ict-excellence-to-computex-2025/ "Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025") [Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025](https://thailandbusinessnews.net/press-release/taiwantrade-com-brings-taiwans-ict-excellence-to-computex-2025/ "Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/silkland-launches-the-first-1-5-meter-passive-thunderbolt-5-cable-to-market/) ## Silkland Launches the First 1.5-Meter Passive Thunderbolt 5 Cable to Market 80Gbps bidirectional bandwidth, 240W USB PD 3.1 EPR, Intel certified – as… [](https://thailandbusinessnews.net/press-release/jcet-reports-79-4-yoy-growth-in-h1-2026-net-profit-attributable-to-shareholders-accelerates-advanced-packaging-expansion-2/) ## JCET Reports 79.4% YoY Growth in H1 2026 Net Profit Attributable to Shareholders, Accelerates Advanced Packaging Expansion SHANGHAI, Aug. 20, 2026 /PRNewswire/ — JCET Group (SSE: 600584), a leading… [](https://thailandbusinessnews.net/press-release/jcet-reports-79-4-yoy-growth-in-h1-2026-net-profit-attributable-to-shareholders-accelerates-advanced-packaging-expansion/) ## JCET Reports 79.4% YoY Growth in H1 2026 Net Profit Attributable to Shareholders, Accelerates Advanced Packaging Expansion SHANGHAI, Aug. 20, 2026 /PRNewswire/ — JCET Group (SSE: 600584), a leading… [](https://thailandbusinessnews.net/press-release/inflow-inventory-launches-lot-number-and-expiry-date-tracking/) ![inFlow Inventory launches lot number and expiry date tracking](https://i0.wp.com/mmx.prnasia.com/media/MS1885030/inFlow-Inventory-inFlow-Inventory-launches-lot-number-and-expiry.jpg?resize=260%2C140&ssl=1 "inFlow Inventory launches lot number and expiry date tracking") ## inFlow Inventory launches lot number and expiry date tracking Small manufacturers and distributors in food, beverage, pharmaceutical and medical…